產品描述: SGX523 is a exquisitely selective and ATP-competitive MET inhibitor. SGX523 potently inhibits MET with an IC50 of 4 nM and is >1,000-fold selective versus other protein kinases. Antitumor activity |
靶點:
c-Met/HGFR;Raf;p38MAPK;c-Met/HGFR;Bcr-Abl |
體內研究:
SGX523 exhibits antitumor activity in vivo. SGX523 inhibits MET-dependent tumor growth |
參考文獻:
1. Buchanan SG, et al. SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo. Mol Cancer Ther, 2009, 8(12), 3181-3190. |
溶解性:
DMSO : 30 mg/mL (83.47 mM; Need ultrasonic) |
保存條件:
-20℃ |
配置溶液濃度參考:
|
1mg |
5mg |
10mg |
1 mM |
2.782 ml |
13.911 ml |
27.823 ml |
5 mM |
0.556 ml |
2.782 ml |
5.565 ml |
10 mM |
0.278 ml |
1.391 ml |
2.782 ml |
50 mM |
0.056 ml |
0.278 ml |
0.556 ml |
|
注意: |
部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。 |